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The precise role played by apolipoproteins in the overall
structural organization of plasma lipoproteins is still
unknown (1). The A apolipoproteins are the principal
constituents of the high density lipoprotein (HDL) class.
In man and nonhuman primates HDL contains both apo
A-I and apo A-IT. Human apo A-II consists of two
identical chains linked by a single disulfide bridge,
whereas in the monkey, apo A-II is a single chain molecule
due to the absence of cisteine. The only disulfide of human
apo A-II is readily amenable to reduction and alkylation,
thus permitting the in vitro production of human single-
chain apo A-II. In lower animal species, HDL contains no
apo A-TI; yet this lipoprotein has structural features which
closely resemble those of man.
RESULTS
Based on the above information and on the fact that the
functional role of apo A-TI is yet undetermined, we elected
to use canine HDL as a model to study the structural and
functional effects caused on this lipoprotein by the addi-
tion of graded amounts of two- or one-chain apo A-IT.
These studies were favored by the knowledge of the
properties of apo A-I and apo A-IT in solution showing a
different mode of self-association for apo A-I and apo A-IT
and between two-chain or one-chain apo A-IT, whether
naturally occurring (rhesus monkey) or obtained from the
reduction and alkylation of human apo A-TI (2). We also
have evidence for a greater affinity of apo A-TI relative to
apo A-I for the hydrophilic:hydrophobic interface. At the
glass bead:water interface, it has been estimated' that the
'Shen, B. Unpublished results.
A Gaff for apo A-I is -9.1 kcal/mol and that of apo A-II is
-10.5 kcal/mol.
The addition at room temperature of lipid-free human
apo A-II (two-chain) to canine HDL results in the uptake
of this apoprotein by HDL and a concomitant displace-
ment of apo A-I into the aqueous solution (3). The
reaction, which is attended by no loss of lipid, is stoichiom-
etric in that by varying the initial free apo A-II-apo A-I
(HDL) ratio, one can show that per mole of apo A-I
displaced, there are 2 mol apo A-II occupying the HDL
surface. Thus, one obtains hybrid particles having the
lipids of canine HDL and varying proportions of human
apo A-II and canine apo A-I at the surface. In the extreme
case, all of the protein mass in the hybrid particle is apo
A-Il with a calculated maximal occupancy of 6 mol/
particle (- 220,000 mol wt). In such a system apo A-Il is
never found free in solution even in the presence of
phospholipid vesicles, which act as scavengers of the
released apo A-I.
To a lesser degree, single-chain apo A-Il either from
natural sources (rhesus apo A-Il) or reduced and alkylated
human apo A-Il are also effective (4) in displacing apo
A-I from the surface of canine HDL, and the hybrid
products formed exhibit differences which are both quan-
titative and qualitative. As shown in Fig. 1, the end
products of the interaction between single-chain apo A-Il
and canine HDL are the HDL-apo A-Il hybrid and free
apo A-I. In turn, the incubation of two-chain apo A-II
with canine HDL results in an additional component likely
representing an apo A-I:apo A-II complex containing
7% phospholipids. This component is particularly evident
when two-chain apo A-II is incubated with HDL in apo
A-II:apo A-I molar ratios exceeding maximal apoprotein
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FIGURE 1 Density gradient elution profiles and SDS gel electrophoretic patterns obtained for products formed upon interaction of two- and
one-chain apo A-Il with canine HDL. Apo A-II either two-chain or S-carboxymethylated one-chain (reduced with mercaptoethanol and
alkylated with iodoacetamide) was incubated at 250C for 30 min with canine HDL at an initial A-II:A-I weight ratio of 3.5:1. The mixture
was then centrifuged on a curvilinear NaBr density gradient (d 1.075-1.35 g/ml) in a Beckman SW 40 rotor at 140C for 66 h (Beckman
Instruments, Fullerton, CA). The eluates were simultaneously scanned at 280 nm and collected (0.4 ml/fraction). Electrophoresis of each
fraction was carried out in 0.1% SDS-10% acrylamide and subsequently stained with Coomassie Blue.
occupancy on the lipoprotein surface. We have also
observed this component in experiments wherein hybrids
containing apo A-II and apo A-I in a weight ratio of 1:1
were cross-linked with dimethylsuberimidate and then
subjected to the displacing action of two-chain apo A-TI.
The main resulting product was the cross-linked HDL
hybrid resistant to the action of apo A-TI, and an added
component banding at d 1.15 g/ml similar in composition
to the apo A-T:apo A-1T:phospholipid complex noted
previously.
DISCUSSION
Several points emerge from these results: (a) apo A-TI
prefers the hydrophilic-hydrophobic interface of the HDL
particle over the aqueous environment; (b) apo A-II has a
significantly greater affinity than apo A-I for the HDL
surface; (c) this difference in affinity appears to be respon-
sible for the displacement of apo A-I by apo A-TI from the
HDL surface; (d) contrary to apo A-IT, apo A-I can be
free in the aqueous medium likely to be in equilibrium
with the molecules at the HDL surface; (e) the overall
structural organization of HDL is unaffected whether apo
A-I or apo A-II alone or mixtures thereof are at the HDL
surface.
The implication of these findings in terms of HDL
structure is that apo A-I does not interact strongly with
any component of the lipoprotein particle and that its
conformation at the interface permits this apoprotein to be
replaced by an adequate amphiphile such as apo A-II. The
latter has a comparatively stronger affinity for the HDL
surface and thus can readily occupy areas previously
containing apo A-I.
These conclusions may not be limited to the HDL
particles. Studies in this laboratory have shown that a
similar competition of apo A-IT and apo A-I for the
hydrophilic-hydrophobic interface occurs when using
single-bilayer vesicles with a phosphatidylcholine:choles-
terol molar ratio of 4:1 (5). A possible physiological
significance of these findings comes from the observation
that the modulation of the proportions of apo A-TI and apo
A-I in HDL is one of the determinants in the action of the
enzyme lecithin:cholesterol acyl transferase. These studies
have shown that apo A-II can inhibit the action of this
enzyme by displacing activator apo A-I from the HDL
particle.
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